Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Long-Term Deferred Tax: 2023-2025

Historic Long-Term Deferred Tax for Sunshine Biopharma (SBFM) over the last 1 years, with Sep 2025 value amounting to $92,234.

  • Sunshine Biopharma's Long-Term Deferred Tax was N/A to $92,234 in Q3 2025 from the same period last year, while for Sep 2025 it was $92,234, marking a year-over-year change of. This contributed to the annual value of $92,234 for FY2024, which is 47.82% down from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Long-Term Deferred Tax is $92,234, which was down 0.00% from $92,234 recorded in Q2 2025.
  • Over the past 5 years, Sunshine Biopharma's Long-Term Deferred Tax peaked at $176,764 during Q4 2023, and registered a low of $92,234 during Q4 2024.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $92,234 (2025), whereas its average is $109,140.
  • Data for Sunshine Biopharma's Long-Term Deferred Tax shows a maximum YoY tumbled of 47.82% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Sunshine Biopharma's Long-Term Deferred Tax stood at $176,764 in 2023, then tumbled by 47.82% to $92,234 in 2024, then reached $92,234 in 2025.
  • Its Long-Term Deferred Tax was $92,234 in Q3 2025, compared to $92,234 in Q2 2025 and $92,234 in Q1 2025.